Reuters logo
2 个月前
BRIEF-Fortress Biotech subsidiary enters into license agreements with City Of Hope
2017年6月5日 / 中午12点17分 / 2 个月前

BRIEF-Fortress Biotech subsidiary enters into license agreements with City Of Hope

June 5 (Reuters) - Fortress Biotech Inc:

* Fortress Biotech announces that its subsidiary, Mustang Bio, enters into license agreements with City Of Hope for novel CAR T immunotherapies

* Fortress Biotech Inc - therapies covered under agreements include human epidermal growth factor receptor 2 (HER2) CAR T technology (HER2 technology)

* Fortress Biotech Inc - therapies covered under agreements include CS1-specific CAR t technology , prostate stem cell antigen (PSCA) CAR T technology

* Fortress Biotech Inc -agreement builds on established exclusive patent license agreements unit entered into with COH related to unit's lead CAR T therapies Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below